In addition, the levels of an activation marker such as CD69 on the γδ T cells from COVID-19 patients were not substantially altered relative to non-COVID-19-infected controls, suggesting that this activation status could be a general reflection of a severe condition rather than a SARS-CoV-2 signature. Here, CD69 is linked to COVID-19.